BTI
TXG icon

Blue Trust Inc’s 10x Genomics TXG Stock Holding History

Blue Trust Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-80
Closed -$935 – 2729
2025
Q3 		$935 Sell
80
-4,814
-98% -$62.8K ﹤0.01% 2339
2025
Q2 		$56.7K Buy
4,894
+1,590
+48% +$14.5K ﹤0.01% 1370
2025
Q1 		$28.8K Sell
3,304
-8
-0.2% -$101 ﹤0.01% 1561
2024
Q4 		$47.6K Buy
3,312
+1,536
+86% +$24.2K ﹤0.01% 1344
2024
Q3 		$34.5K Buy
1,776
+1,025
+136% +$21.2K ﹤0.01% 1725
2024
Q2 		$28.2K Buy
751
+717
+2,109% +$18.8K ﹤0.01% 1515
2024
Q1 		$1.28K Sell
34
-291
-90% -$12.8K ﹤0.01% 1896
2023
Q4 		$13K Buy
+325
New +$14.1K ﹤0.01% 1494
2023
Q2 		– Sell
-14
Closed -$1K – 2530
2023
Q1 		$1K Sell
14
-29
-67% -$1.35K ﹤0.01% 2217
2022
Q4 		$1K Buy
43
+31
+258% +$1.01K ﹤0.01% 2147
2022
Q3 		$0 Buy
+12
New +$457 ﹤0.01% 2329

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Blue Trust Inc's TXG Position: Q4 2025 in Review

Blue Trust Inc sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 80 shares — an estimated $935 sold.

Blue Trust Inc first reported a position in TXG in Q3 2022 and held it in 11 quarters. The position peaked at $56.7K in Q2 2025. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Blue Trust Inc reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 80 10x Genomics shares in Q4 2025, an estimated $935.
  • Blue Trust Inc first reported a position in 10x Genomics in Q3 2022 and held it in 11 quarters.
  • Blue Trust Inc's 10x Genomics position peaked at $56.7K in Q2 2025.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.